Kenneth A. Stauderman, Chief Scientific Officer at CalciMedica, Inc. (CALC), bought 1,000 shares at $3.96 ($4K) on 2025-07-28, disclosed to the SEC on 2025-07-29.
Open-market purchase of $4k CALC by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.